CellSource Co., Ltd. (TYO:4880)
Japan · Delayed Price · Currency is JPY 315.00
+7.00 (2.27%)
Aug 6, 2026, 1:15 PM JST
CellSource Market Cap
CellSource has a market cap or net worth of 6.11 billion as of August 5, 2026. Its market cap has decreased by -54.56% in one year.
Market Cap
6.11B
Enterprise Value
1.33B
Revenue
3.67B
Ranking
n/a
PE Ratio
87.23
Stock Price
315.00
ChartMarket Cap Chart
Since October 29, 2019, CellSource's market cap has decreased from 13.48B to 6.11B, a decrease of -54.65%. That is a compound annual growth rate of -11.02%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2026 | 6.11B | -22.71% |
| Dec 30, 2025 | 7.91B | -52.01% |
| Dec 30, 2024 | 16.48B | -34.91% |
| Dec 29, 2023 | 25.32B | -66.16% |
| Dec 30, 2022 | 74.83B | -26.01% |
| Dec 30, 2021 | 101.14B | 51.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| StemCell Institute | 7.35B |
| BrightPath Biotherapeutics | 7.08B |
| ADR Biomedical Holdings | 7.08B |
| MEDINET | 7.04B |
| Carna Biosciences | 6.32B |
| Noile-Immune Biotech | 6.03B |
| Chordia Therapeutics | 6.03B |
| PRISM BioLab Co.,LTD | 6.03B |